A global law firm with a distinguished heritage, Baker Botts is a leader in the field of IP law.
With over 150 lawyers— who together hold 166 technical degrees, have 105 pending patent litigations throughout the U.S., and have more than 280 PTAB appearances — Baker Botts’ Intellectual Property legal team offers the strength and depth needed to provide sophisticated advice and counseling on a truly international scale. In 2014, we conducted 14 Markman hearings; tried 3 cases to a jury, including a seminal case at the ITC on a novel theory of trade secret misappropriation. We have filed more than 1,542 new U.S. and 817 international patent applications since 2013. Our size, technical horsepower, breadth of services, and significant results for some of the world’s most important technology clients sets Baker Botts apart from other full-service IP law firms.
The complex technology issues of today that confront many of our clients are being addressed in a number of jurisdictions around the world, and Baker Botts has the capabilities to support our clients in those venues, with IP lawyers across our global offices. Our lawyers realize that ideas and brands are more than just words and images; they are key elements to a company’s business strategy and a foundation for growth.
Baker Botts has one of the largest IP legal teams, offering clients experience in the combination of legal, scientific, technical and medical fields in a variety of industries. An overview of our services includes:
- Strategic IP counseling
- Patent and trademark acquisition
- Patent, trademark and copyright litigation (including International Trade Commission and Hatch-Waxman Act litigation)
- Copyright management and licensing
Under this suite of services, some of what we offer clients includes:
- Patent portfolio management and audits
- Patent opinions
- Patent licensing
- Trademark portfolio management
- Technology licensing
Our IP team has acted for clients in a wide range of industry sectors and technologies, including:
- Oil and gas
- Industrial machinery and heavy engineering
- IT/software and environmental engineering
Our IP lawyers have represented clients in the Patent Court and the Court of Appeal and in matters before international offices. When the issue is litigation, the firm’s Intellectual Property Department has particular experience in complex, high-stakes patent, trade secret, trademark and copyright litigation nationwide and across the globe.
Unlike most general practice law firms, Baker Botts offers a full-service IP practice. The core areas of our IP practice include obtaining patents and other IP rights for our clients, but also handling all manners of IP transactions and enforcing IP rights, including litigating IP disputes through trial and final appeal. According to IAM Patent 1000 2015, the firm’s “...multi-talented patent lawyers are equally at home running mission-critical litigations, managing substantial prosecution dockets or brokering heavyweight IP transactions.”
Our IP clients are as diverse as the work we perform. We represent large multi-national companies and small start-up operations as well as universities, industry associations and research consortia. Our IP services are designed to specifically meet the needs, size and scope of our clients and to evolve with our clients as their needs and businesses change.
Publications, Speeches & Presentations
New York Law Journal
Wolters Kluwer Strategic Perspectives
Wolters Kluwer Legal & Regulatory, U.S.
Join us May 31st through June 1st and see why the Rocky Mountain Intellectual Property & Technology Law Institute is the best way to turbo-charge your IP practice!
On Wednesday 6 June, Baker Botts will be hosting the seminar, M&A in Uncertain Times: Planning for Growth with Citco.
Join us on June 7th for the Managing Intellectual Property International Women's Leadership Forum that will focus on international IP.
Join us to hear more about relevant IP topics including Supreme Court topics and other recent trends.
Baker Botts Intellectual Property Partner Margaret J. Sampson will speak on "Using the FDA and Patent Overlap to Protect Market Exclusivity."